Your search returned 3146 results.

Results
	481.	Diabetes: Lixisenatide does not increase rates of CVD events. [electronic resource] by Huynh, Karina Producer: 20160516 In: Nature reviews. Cardiology vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	482.	Morphologically 'invisible' proinsulin - secreting adenoma detected by Ga-68 Exendin-4 (GLP-1 Receptor) positron emission tomography/CT. [electronic resource] by Werner, Christoph Lupp, Amelie Drescher, Robert Freesmeyer, Martin Mireskandari, Masoud Stoykow, Christian Bauschke, Astrid Müller, Ulrich A Producer: 20181001 In: Journal of medical imaging and radiation oncology vol. 62 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	483.	Lixisenatide in Type 2 Diabetes and Acute Coronary Syndrome. [electronic resource] by Pfeffer, Marc A Claggett, Brian Probstfield, Jeffrey L Producer: 20160317 In: The New England journal of medicine vol. 374 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	484.	GLP-1, a powerful physiological incretin: an update. [electronic resource] by Malik, J Roohi, N Producer: 20190315 In: Journal of biological regulators and homeostatic agents vol. 32 Availability: No items available. Save to lists Add to cart (remove)
	485.	Dual glucagon-like peptide-1 receptor/glucagon receptor agonist SAR425899 improves beta-cell function in type 2 diabetes. [electronic resource] by Visentin, Roberto Schiavon, Michele Göbel, Britta Riz, Michela Cobelli, Claudio Klabunde, Thomas Dalla Man, Chiara Producer: 20210624 In: Diabetes, obesity & metabolism vol. 22 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	486.	Renal Tubular Glucagon-Like Peptide-1 Receptor Expression Is Increased in Early Sepsis but Reduced in Chronic Kidney Disease and Sepsis-Induced Kidney Injury. [electronic resource] by Choi, Jae Hyun Kim, Seung Jung Kwon, Soon Kil Kim, Hye-Young Jeon, Hyunjung Producer: 20200427 In: International journal of molecular sciences vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	487.	Nephroprotective effects of GLP-1 receptor agonists: where do we stand? [electronic resource] by Mosterd, Charlotte M Bjornstad, Petter van Raalte, Daniël H Producer: 20210818 In: Journal of nephrology vol. 33 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	488.	Glucagon like peptide-1 receptor agonists and di-peptidyl peptidase inhibitors... A new class of drugs for the treatment of diabetes. [electronic resource] by Khan, Muhammad Owais Memon, Adil Iqbal Riaz, Haris Producer: 20091209 In: JPMA. The Journal of the Pakistan Medical Association vol. 59 Availability: No items available. Save to lists Add to cart (remove)
	489.	Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury. [electronic resource] by Greig, Nigel H Tweedie, David Rachmany, Lital Li, Yazhou Rubovitch, Vardit Schreiber, Shaul Chiang, Yung-Hsiao Hoffer, Barry J Miller, Jonathan Lahiri, Debomoy K Sambamurti, Kumar Becker, Robert E Pick, Chaim G Producer: 20141006 In: Alzheimer's & dementia : the journal of the Alzheimer's Association vol. 10 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	490.	Cardiovascular outcome studies in type 2 diabetes: Comparison between SGLT2 inhibitors and GLP-1 receptor agonists. [electronic resource] by Scheen, André J Producer: 20181105 In: Diabetes research and clinical practice vol. 143 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	491.	Series: Implications of the recent CVOTs in type 2 diabetes: Impact on guidelines: The endocrinologist point of view. [electronic resource] by Scheen, André J Producer: 20200406 In: Diabetes research and clinical practice vol. 159 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	492.	The effect of dipeptidyl peptidase-4 inhibitor and glucagon-like peptide-1 receptor agonist in gestational diabetes mellitus: a systematic review. [electronic resource] by Chen, Chengcong Huang, Ying Dong, Guoqing Zeng, Yongmei Zhou, Ziqiong Producer: 20210210 In: Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology vol. 36 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	493.	Type 2 diabetes: pathogenesis and treatment. [electronic resource] by Stumvoll, Michael Goldstein, Barry J van Haeften, Timon W Producer: 20080710 In: Lancet (London, England) vol. 371 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	494.	A glucagon-like peptide-1 (GLP-1) receptor agonist in the treatment for hypothalamic obesity complicated by type 2 diabetes mellitus. [electronic resource] by Thondam, S K Cuthbertson, D J Aditya, B S Macfarlane, I A Wilding, J P Daousi, C Producer: 20130204 In: Clinical endocrinology vol. 77 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	495.	[Safety and tolerability of GLP-1 receptor agonists]. [electronic resource] by Soldevila, Berta Puig-Domingo, Manel Producer: 20180117 In: Medicina clinica vol. 143 Suppl 2 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	496.	GLP-1R activation for the treatment of stroke: updating and future perspectives. [electronic resource] by Darsalia, Vladimer Nathanson, David Nyström, Thomas Klein, Thomas Sjöholm, Åke Patrone, Cesare Producer: 20150330 In: Reviews in endocrine & metabolic disorders vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	497.	GLP-1 receptor agonists in NAFLD. [electronic resource] by Petit, J-M Vergès, B Producer: 20180622 In: Diabetes & metabolism vol. 43 Suppl 1 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	498.	Is GLP-1 a hormone: Whether and When? [electronic resource] by D'Alessio, David Producer: 20170208 In: Journal of diabetes investigation vol. 7 Suppl 1 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	499.	Lixisenatide in Type 2 Diabetes and Acute Coronary Syndrome. [electronic resource] by Tsutsumi, Yusuke Tsujimoto, Yasushi Ikenoue, Tatsuyoshi Producer: 20160317 In: The New England journal of medicine vol. 374 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	500.	Central GLP-1 receptors: Novel molecular targets for cocaine use disorder. [electronic resource] by Hernandez, N S Schmidt, H D Producer: 20200702 In: Physiology & behavior vol. 206 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

First
Previous
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
Next
Last

Refine your search

Availability

Authors

Topics

Languages

Your search returned 3146 results.